These 5 “Magic Formula” Biotech Stocks Are Guru Approved
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
On the heels of Novavax receiving $1.6 billion in federal aid for its COVID-19 vaccine candidate, the author of today’s article advises that “investors might…
High-risk stocks have soared since the March selloff. As the author of today’s article observes, “In essence, most investors on Wall Street are positioning for…
“If you are looking to hit a home run in the stock market, the NASDAQ Composite is a good place to start,” advises the author…
When it comes to biotech stocks, the author of today’s article advises that “While you can get access to many of these firms via exchange-traded…
The two small-cap biotech stocks highlighted in today’s article appear poised to dominate this year and beyond. Why? As the author explains, “Both companies are…
The stock market could be in for an especially volatile time this week and into July – and while the acceleration in new coronavirus cases…
“This pandemic-driven frenzy for drugmaker stocks has made it awfully hard for investors who like to focus on the fundamentals,” notes the author of today’s…
If you’re looking for an options trade with the potential to nearly double your money, today’s article outlines one such trade to consider. Specifically, as…
“Against this backdrop, investors will need to crunch the numbers, to find the stocks that are best positioned for current conditions,” advises the author of…
Could a COVID-19 vaccine – or vaccines – be approved before the November election? That’s the bold prediction being made by Jefferies – and if…